Serum and gene expression profile of cytokines in first-episode psychosis

Di Nicola, Marco, Cattaneo, Annamaria, Hepgul, Nilay, Di Forti, Marta, Aitchison, Katherine J., Janiri, Luigi, Murray, Robin M., Dazzan, Paola, Pariante, Carmine M., Mondelli, Valeria·2013·Brain Behavior and Immunity
DOI 10.1016/j.bbi.2012.06.010

Cited by (217)

Items 101–200 of 217

  1. Decreased use of active coping styles contributes to elevated allostatic load index in first-episode psychosis
    Błażej Misiak, Kamila Kotowicz, Olga Loska, Filip Stramecki, Jan Aleksander Beszłej, Jerzy Samochowiec, Marcin Jabłoński, Piotr Podwalski, Katarzyna Waszczuk, Michał Wroński et al. · 2018 · Psychoneuroendocrinology
  2. Stress, Allostatic Load, and Psychosis: One Step Forward in Research But Where to Go Next?
    Błażej Misiak · 2020 · Frontiers in Psychiatry
  3. The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia
    Levent Turhan, Sedat Batmaz, Sibel Koçbıyık, Arif Haldun Soygur · 2016 · Nordic Journal of Psychiatry
  4. Towards precision medicine: What are the stratification hypotheses to identify homogeneous inflammatory subgroups
    Magdalini Ioannou, Marianne Foiselle, Jasmina Mallet, Elissa L. Stam, Ophélia Godin, Caroline Dubertret, Emilie Terro, Iris E. Sommer, Bartholomeus C. M. Haarman, Marion Leboyer et al. · 2020 · European Neuropsychopharmacology
  5. Cytokine profile in drug-naïve, first episode patients with psychosis
    Petros Petrikis, Paraskevi V. Voulgari, Alexandros T. Tzallas, Dimitra T. Archimandriti, Petros Skapinakis, Venetsanos G. Mavreas · 2015 · Journal of Psychosomatic Research
  6. Impact of antipsychotic treatment on methylation status of Interleukin-6 [IL-6] gene in Schizophrenia
    Deepthi Venugopal, Venkataram Shivakumar, Manjula Subbanna, Sunil V. Kalmady, Anekal C. Amaresha, Sri Mahavir Agarwal, Janardhanan C. Narayanaswamy, Moinak Banerjee, Monojit Debnath, Ganesan Venkatasubramanian · 2018 · Journal of Psychiatric Research
  7. Overdispersed gene expression in schizophrenia
    Guangzao Huang, Daniel Osorio, Jinting Guan, Guoli Ji, James J. Cai · 2020 · Schizophrenia
  8. Brain antibodies in the cortex and blood of people with schizophrenia and controls
    L. J. Glass, Duncan Sinclair, Danny Boerrigter, K Naude, Samantha J. Fung, David Alexander Brown, Vibeke Sorensen Catts, Paul A. Tooney, Maryanne O׳Donnell, Rhoshel Lenroot et al. · 2017 · Translational Psychiatry
  9. The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals
    María Juncal‐Ruíz, Laura Riesco-Dávila, Víctor Ortiz‐García de la Foz, Mariluz Ramírez-Bonilla, Obdulia Martínez‐García, Juan Irure‐Ventura, Juan Carlos Leza, Marcos López‐Hoyos, Benedicto Crespo‐Facorro · 2018 · Journal of Neuroinflammation
  10. Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia
    Honey Kim, Seon-Hwa Baek, Ju‐Wan Kim, Seunghyong Ryu, Ju‐Yeon Lee, Jae‐Min Kim, Young‐Chul Chung, Sung‐Wan Kim · 2023 · Schizophrenia
  11. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis – Results of the randomized controlled Vienna omega-3 study
    Stefan Smesny, Berko Milleit, Miriam R. Schaefer, Jana Hesse, Monika Schlögelhofer, Kerstin Langbein, Uta‐Christina Hipler, Maximus Berger, David Cotter, Heinrich Sauer et al. · 2017 · Schizophrenia Research
  12. Hidradenitis suppurativa and schizophrenia: a nationwide cohort study
    Dana Tzur Bitan, Daniella Berzin, Arnon Dov Cohen · 2019 · Journal of the European Academy of Dermatology and Venereology
  13. Increased prefrontal cortical cells positive for macrophage/microglial marker CD163 along blood vessels characterizes a neuropathology of neuroinflammatory schizophrenia
    Yunting Zhu, Maree J. Webster, Adam K. Walker, Paul T. Massa, Frank A. Middleton, Cynthia Shannon Weickert · 2023 · Brain Behavior and Immunity
  14. Over-expression of TGF-β1 gene in medication free Schizophrenia
    Mahsa Mohammad Amoli, Fatemeh Khatami, Seyed Masoud Arzaghi, Samaneh Enayati, Ali‐Akbar Nejatisafa · 2018 · Psychoneuroendocrinology
  15. The effects of nanocurcumin supplementation on inflammation in hemodialysis patients: A randomized controlled trial
    Golchin Vafadar Afshar, Yousef Rasmi, Parichehreh Yaghmaei, Mohammad‐Hassan Khadem‐Ansari, Khadijeh Makhdoomi, Javad Rasouli · 2021 · Hemodialysis International
  16. Immune cell subsets in patients with bipolar disorder or schizophrenia with history of childhood maltreatment
    Marianne Foiselle, Mohamed Lajnef, Nora Hamdani, Wahid Boukouaci, Ching‐Lien Wu, Soumia Naamoune, Leïla Chami, Esma Mezoued, Jean‐Romain Richard, Jihène Bouassida et al. · 2023 · Brain Behavior and Immunity
  17. The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence
    Alexis E. Cullen, Javier Labad, Dominic Oliver, Adam Al‐Diwani, Amedeo Minichino, Paolo Fusar‐Poli · 2023 · Current Neuropharmacology
  18. Influence of correlation between HLA-G polymorphism and Interleukin-6 (IL6) gene expression on the risk of schizophrenia
    Venkataram Shivakumar, Monojit Debnath, Deepthi Venugopal, Ashwini Rajasekaran, Sunil V. Kalmady, Manjula Subbanna, Janardhanan C. Narayanaswamy, Anekal C. Amaresha, Ganesan Venkatasubramanian · 2017 · Cytokine
  19. Elevated serum vascular endothelial growth factor in treatment-resistant schizophrenia treated with electroconvulsive therapy: Positive association with therapeutic effects
    Wenhuan Xiao, Qiongqiong Zhan, Fei Ye, Xiaowei Tang, Jin Li, Hui Dong, Weiwei Sha, Xiaobin Zhang · 2018 · The World Journal of Biological Psychiatry
  20. Involvement of vascular endothelial growth factor in schizophrenia
    Antonio Rampino, Tiziana Annese, Silvia Torretta, Roberto Tamma, Rosa Maria Falcone, Doménico Ribatti · 2021 · Neuroscience Letters
  21. Lack of association of IL-6 (−174 G>C) and TNF-α (−238 G>A) variants with paranoid schizophrenia in Indian Bengalee population
    Monojit Debnath, Bikash Mitra, Nirmal Kumar Bera, Tapas Kumar Chaudhuri, Ya‐Ping Zhang · 2012 · Cytokine
  22. Effects of IL-6/IL-6R axis alterations in serum, plasma and cerebrospinal fluid with the schizophrenia: an updated review and meta-analysis of 58 studies
    Thelma Beatriz González‐Castro, Carlos Alfonso Tovilla‐Zárate, Isela Esther Juárez‐Rojop, Yazmín Hernández‐Díaz, María Lilia López‐Narváez, Rosa Felicita Ortíz Ojeda · 2023 · Molecular and Cellular Biochemistry
  23. Cytokine alterations in first-onset postpartum psychosis-clues for underlying immune dysregulation
    Gopinath Sathyanarayanan, Harish Thippeswamy, Reeta Subramaniam Mani, Manjunatha M. Venkataswamy, Mahesh M. Kumar, Mariamma Philip, Prabha S. Chandra · 2019 · Asian Journal of Psychiatry
  24. Neurotrophic factors, childhood trauma and psychiatric disorders: A systematic review of genetic, biochemical, cognitive and imaging studies to identify potential biomarkers
    Maria Grazia Di Benedetto, Catia Scassellati, Nadia Cattane, Marco Andrea Riva, Annamaria Cattaneo · 2022 · Journal of Affective Disorders
  25. Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia
    Wenhuan Xiao, Qiongqiong Zhan, Fei Ye, Xiaowei Tang, Jin Li, Hui Dong, Weiwei Sha, Xiaobin Zhang · 2018 · European Neuropsychopharmacology
  26. Immune abnormalities across psychiatric disorders: clinical relevance
    Mondelli, Valeria, Dazzan, Paola, Pariante, Carmine M. · 2015 · BJPsych Advances
  27. Measurement of anti-suprabasin antibodies, multiple cytokines and chemokines as potential predictive biomarkers for neuropsychiatric systemic lupus erythematosus
    Trang T.T. Hoang, Kunihiro Ichinose, Shimpei Morimoto, Kaori Furukawa, Ly H.T. Le, Atsushi Kawakami · 2022 · Clinical Immunology
  28. Inteurleukin-8 gene variations and the susceptibility to schizophrenia
    Amira Ben Afia, Youssef Aflouk, Hana Saoud, Farid Zaafrane, Lotfi Gaha, Besma Bel Hadj Jrad · 2020 · Psychiatry Research
  29. Common and disorder-specific upregulation of the inflammatory markers TRAIL and CCL20 in depression and schizophrenia
    Federica Klaus, Karoline Guetter, Rebecca Schlegel, Tobias R. Spiller, Erich Seifritz, Flurin Cathomas, Stefan Kaiser · 2021 · Scientific Reports
  30. The neural, stress hormone and inflammatory correlates of childhood deprivation and threat in psychosis: A systematic review
    Megan Thomas, Divyangana Rakesh, Sarah Whittle, Margaret A. Sheridan, Rachel Upthegrove, Vanessa Cropley · 2023 · Psychoneuroendocrinology
  31. Immune-Related Genomic Schizophrenic Subtyping Identified in DLPFC Transcriptome
    Eva P. Childers, Elijah F. W. Bowen, C. Harker Rhodes, Richard Granger · 2022 · Genes
  32. Active psychosis and pro-inflammatory cytokines in first-episode of psychosis
    G. Pardo de Santayana, María Juncal‐Ruíz, Javier Vázquez-Bourgón, Laura Riesco-Dávila, Víctor Ortiz‐García de la Foz, José María Pelayo‐Terán, Marcos López‐Hoyos, Benedicto Crespo‐Facorro · 2020 · Journal of Psychiatric Research
  33. Clinical Perspectives on Targeting Therapies for Personalized Medicine
    Donald R.J. Singer, Zoulikha M. Zaïr · 2015 · Advances in protein chemistry and structural biology
  34. The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis
    Fabiana Maria das Graças Corsi Zuelli, Leonardo André da Costa Marques, Daiane Leite da Roza, Camila Marcelino Loureiro, Rosana Shuhama, Marta Di Forti, Paulo Rossi Menezes, Paulo Louzada‐Júnior, Cristina Marta Del‐Ben · 2021 · Psychological Medicine
  35. The role of the immune system in postpartum psychosis
    Katie M. Hazelgrove · 2021 · Brain Behavior & Immunity - Health
  36. The Interrelationships between Cytokines and Schizophrenia: A Systematic Review
    Haibing Lv, Meng Guo, Guo Chuang, Kuanjun He · 2024 · International Journal of Molecular Sciences
  37. The role of infections and inflammation in schizophrenia: review of the evidence
    Gellan K. Ahmed, Haidi Karam‐Allah Ramadan, Khaled Elbeh, Nourelhoda A. Haridy · 2024 · Middle East Current Psychiatry
  38. Altered serum levels of vascular endothelial growth factor in first-episode drug-naïve and chronic medicated schizophrenia
    Fei Ye, Qiongqiong Zhan, Wenhuan Xiao, Xiaowei Tang, Jin Li, Hui Dong, Weiwei Sha, Xiaobin Zhang · 2018 · Psychiatry Research
  39. Protective Effect of the MCP-1 Gene Haplotype against Schizophrenia
    Hana Saoud, Oumaima Inoubli, Sihem Ben Fredj, Mohsen Hassine, Bochra Ben Mohamed, Lotfi Gaha, Besma Bel Hadj Jrad · 2019 · BioMed Research International
  40. The association between peripheral inflammation, brain glutamate and antipsychotic response in Schizophrenia: Data from the STRATA collaboration
    Sunniva Fenn‐Moltu, J.F.W. Deakin, Richard Drake, Oliver David Howes, Stephen M. Lawrie, Shôn W. Lewis, Naghmeh Nikkheslat, James Walters, James Hunter MacCabe, Valeria Mondelli et al. · 2023 · Brain Behavior and Immunity
  41. Anti-Inflammatory Activity of the Constituents from the Leaves of Perilla frutescens var. acuta
    Isoo Pauli Youn, Su-Jin Han, Hee Jin Jung, Sang Gyun Noh, Hae Young Chung, Yean Kyoung Koo, Sunhye Shin, Eun Kyoung Seo · 2023 · Pharmaceuticals
  42. Potential role between inflammatory cytokines and Tie-2 receptor levels and clinical symptoms in patients with first-episode schizophrenia
    Fanfan Yan, Xiaojing Meng, Xialong Cheng, Wenzhi Pei, Yuanyuan Chen, Long Chen, Mingming Zheng, Li Shi, Cuizhen Zhu, Xulai Zhang · 2023 · BMC Psychiatry
  43. Genetic and inflammatory effects on childhood trauma and cognitive functioning in patients with schizophrenia and healthy participants
    Emma Corley, Saahithh Redddi Patlola, Aodán Laighneach, Aiden Peter Corvin, Ross McManus, Marcus Kenyon, John P. Kelly, Declan Patrick McKernan, Sinéad King, Brian P. Hallahan et al. · 2023 · Brain Behavior and Immunity
  44. Psychosis of Epilepsy: An Update on Clinical Classification and Mechanism
    Zhiruo Qiu, Jiahui Guo, Bofei Chen, Jiajia Fang · 2025 · Biomolecules
  45. Neurodegenerative Aspects in Vulnerability to Schizophrenia Spectrum Disorders
    Trevor Archer, Serafino Ricci, Danilo Garcia, Max Rapp Ricciardi · 2014 · Neurotoxicity Research
  46. Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
    Kati Koido, Jürgen Innos, Liina Haring, Mihkel Zilmer, Aigar Ottas, Eero Vasar · 2016 · Frontiers in Neuroscience
  47. Cannabis Influences the Putative Cytokines-Related Pathway of Epilepsy among Egyptian Epileptic Patients
    Yasmeen M. Taalab, Wessam Mustafa, Manar A. Helmy, Alyaa Othman, Mohamed Darwish, Ibrahim Hassan, Mohammed Abd Allah Abbas · 2019 · Brain Sciences
  48. Alzheimer’s Disease-Related Psychosis: An Overview of Clinical Manifestations, Pathogenesis, and Current Treatment
    Amira Yasmine Benmelouka, Yassamine Ouerdane, Oumaima Outani, Y. Alnasser, Badrah Saeed Ali Alghamdi, Asma Perveen, Ghulam Md Ashraf, Mahmoud Ahmed Ebada · 2022 · Current Alzheimer Research
  49. Risk of psychosis in autism spectrum disorder individuals exposed to psychosocial stressors: A 9‐year chart review study
    Riccardo Bortoletto, Lorenzo Bassani, Marco Garzitto, Marco Lamberti, Alessandro Simonati, Francesca Darra, Sagnik Bhattacharyya, Carla Comacchio, Matteo Balestrieri, Donatella Arcangeli et al. · 2023 · Autism Research
  50. Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial
    Mareike Aichholzer, Shiral S. Gangadin, Iris E. Sommer, Annemarie J. M. Wijkhuijs, Lot D. de Witte, René S. Kahn, Sabine Bahn, Hemmo A. Drexhage, Carmen Schiweck · 2022 · Brain Behavior & Immunity - Health
  51. Chronic schizophrenia is associated with over-expression of the interleukin-2 receptor gamma gene.
    Hovsep Ghazaryan, M. Petrek, A. Boyajyan · 2014 · Psychiatry Research
  52. Clinical and Diagnostic Value of High-Density Lipoprotein-Based Inflammatory Indices and Lipid Ratios in Young Adults with Schizophrenia
    Liling Chen, Cunqing Zheng, Honglin Luan, Xinyuan Chen · 2024 · Journal of Inflammation Research
  53. Schizophrenia and cancer: Is angiogenesis a missed link?
    Rui Lopes, Raquel A. Soares, Margarida Figueiredo‐Braga, Rui C. Coelho · 2014 · Life Sciences
  54. Molecular Evidence for Altered Angiogenesis in Neuroinflammation-Associated Schizophrenia and Bipolar Disorder Implicate an Abnormal Midbrain Blood-Brain Barrier
    Yunting Zhu, Maree J. Webster, Gerardo Mendez Victoriano, Frank A. Middleton, Paul T. Massa, Cynthia Shannon Weickert · 2024 · Schizophrenia Bulletin
  55. The influence of childhood trauma on aggression and violent behavior in first episode psychosis: A critical review
    Jill Del Pozzo, Julie Walsh‐Messinger, Daniel Antonius · 2021 · Aggression and Violent Behavior
  56. The Future of Psychoneuroimmunology: Promises and Challenges
    Angelos E Halaris, Karl Bechter, Ebrahim Haroon, Brain E. Leonard, Andrew H. Miller, Carmine Maria Pariante, Patricia A. Zunszain · 2018 · Springer eBooks
  57. Immune‐mediated inflammatory markers in acute and transient psychotic disorders—comparison with schizophrenia: An exploratory comparative study
    Akshayee Kale, Debasish Basu, Swapnajeet Sahoo, Ranjana W. Minz · 2022 · Early Intervention in Psychiatry
  58. Investigating the relationship between toll-like receptor activity, low-grade inflammation and cognitive deficits in schizophrenia patients – A mediation analysis
    Saahithh Redddi Patlola, Laurena Holleran, Maria Regina Dauvermann, Karolina Rokita, Aodán Laighneach, Brian P. Hallahan, Ross McManus, Marcus Kenyon, Colm McDonald, Derek W. Morris et al. · 2025 · Brain Behavior and Immunity
  59. Transcriptomic Data Analysis Reveals a Down-Expression of Galectin-8 in Schizophrenia Hippocampus
    Maria Cristina Petralia, Rosella Ciurleo, Alessia Bramanti, Placido Bramanti, Andrea Saraceno, Katia Mangano, Maria Catena Ausilia Quattropani, Ferdinando Nicoletti, Paolo Fagone · 2021 · Brain Sciences
  60. Impact of Childhood Adversity, as Early Life Distress, on Cytokine Alterations in Schizophrenia
    Čedo Miljević, Ana Munjiza, Teodora Jovanović · 2023 · Neuropsychiatric Disease and Treatment
  61. Clinical Relevance of Peripheral Interleukins in Drug-Naive First-Episode Psychosis: Symptom-Specific Associations from the PANSS Dimensions
    Iva Binić, Jovana Petrovic, Olivera Žikić, S. Tošić-Golubović, V. Djordjevic, Marko Stevanovic, Dane Krtinić, Marija Andjelkovic Apostolovic · 2025 · Brain Sciences
  62. A functional polymorphism in the interleukin-1beta and severity of nicotine dependence in male schizophrenia: A case-control study
    Xiang Yang Zhang, Da-Chun Chen, Yun-Long Tan, Shu-ping Tan, Xingguang Luο, Lingjun Zuo, Wen‐Wang Rao, Qiong Yu, Changgui Kou, Melissa Allen et al. · 2015 · Journal of Psychiatric Research
  63. Inflammatory parameters in sexually abused children
    Kilic Serbulent, Özlem Kara, Murat Tutanç · 2017 · Saudi Medical Journal
  64. Male-biased vulnerability of mouse brain tryptophan/kynurenine and glutamate systems to adolescent exposures to concentrated ambient ultrafine particle air pollution
    Deborah A. Cory‐Slechta, Elena Marvin, Kevin A. Welle, Calla M. Goeke, David Chalupa, Günter Oberdörster, Marissa Sobolewski · 2024 · NeuroToxicology
  65. Navigating a complex landscape – A review of the relationship between inflammation and childhood trauma and the potential roles in the expression of symptoms of depression
    Courtney Worrell · 2022 · Brain Behavior & Immunity - Health
  66. Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α (TNF-α) levels in patients with schizophrenia
    Atike Gül Çakıl, Hasan Kaya, Arzu Sakallı Nural, Işık Batuhan Çakmak, İhsan Tuncer Okay, Erol Göka · 2023 · Psychopharmacology
  67. Evaluation of IL-1β, IL-6, and inflammatory markers during exacerbation and after antipsychotic treatment in drug-free schizophrenia patients
    Salih Kalyoncu, Hasan Mervan Aytaç, Oya Güçlü · 2025 · International Journal of Psychiatry in Clinical Practice
  68. Cytokine profile among a sample of bipolar and schizophrenic patients: a comparative study
    Shaimaa M Arafa, Shaimaa Abdelhafeez · 2020 · Egyptian Journal of Psychiatry
  69. The role of environmental factors in the etiology of schizophrenia
    Kinga Brzuszkiewicz, Gracjan Rudziński, Borys Łozowski, Przemysław Raczkiewicz, Natalia Kusak, Ewelina Soroka · 2023 · Journal of Education Health and Sport
  70. The Influence of Gut Microbiota in Psychosis
    Nuala Murray, Reza Hosseini Ghomi, Katlyn Nemani, K. O’Connor · 2024 · Elsevier eBooks
  71. Social connections are differentially related to subjective age and physiological age acceleration amongst older adults
    Daisy E. Fancourt, Andrew Steptoe, Mikaela Bloomberg · 2026 · Nature Communications
  72. Cryoglobulins as Potential Triggers of Inflammation in Schizophrenia
    Andranik Chavushyan, Meri Hovsepyan, Anna S. Boyajyan · 2013 · Schizophrenia Research and Treatment
  73. Maternal immune activation during gestation modulates offspring immune profiles in a nonhuman primate model
    Chelsea Kelland, Joseph D. Schauer, Ana‐Maria Iosif, Steven M. Rollins, Apurv Srivastav, Tyler A. Lesh, Casey E. Hogrefe, Cynthia Mills Schumann, Cameron Carter, Kimberley McAllister et al. · 2025 · Brain Behavior and Immunity
  74. Cytokine changes in clinical high risk for psychosis population following antipsychotic medication
    Yanyan Wei, LiHua Xu, D. H. Zhang, Jiahui Zeng, XiaoChen Tang, ZhengHui Yi, HaiChun Liu, MingLiang Ju, HuiRu Cui, Yingying Tang et al. · 2026 · Translational Psychiatry
  75. Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis
    Martino Belvederi Murri, Riccardo Guglielmo, Alessio Zizzi, Angela Muscettola, Maria Giulia Nanni, Manuela Dall’Oro, Gianluca Serafini, Alberto Inuggi, Andrea Escelsior, Mario Amore et al. · 2026 · Brain Behavior and Immunity
  76. Cultural Engagement Is Related to Decelerated Physiological Age: Doubly Robust Estimations in a National Cohort Study
    Daisy E. Fancourt, Saoirse Finn, Hei Wan Mak, Andrew Steptoe, Mikaela Bloomberg · 2026 · Annals of the New York Academy of Sciences
  77. Differential inflammatory profiles in carriers of reciprocal 22q11.2 copy number variants
    Kathleen O’Hora, Carolyn Amir, Emily Chiem, Charles H. Schleifer, Vardui Grigoryan, Leila Kushan, Jessica J. Chiang, Steve W. Cole, Michael R. Irwin, Carrie E. Bearden · 2024 · Psychoneuroendocrinology
  78. Involvement of virus infections and antiviral agents in schizophrenia
    Alejandro Borrego-Ruiz, Juan José Borrego · 2025 · Psychological Medicine
  79. Clinical and Biological Overlap between Schizophrenia, Autism Spectrum Disorder, and Trauma and Stress-Related Disorders: The Three-Tree Model of SCZ-ASD-TSRD
    Hitomi Shimizu, Yoshiro Morimoto, Naoki Yamamoto, Hirokazu Kumazaki, Hiroki Ozawa, Akira Imamura · 2022 · IntechOpen eBooks
  80. Suppressed transcript diversity and immune response in COVID-19 ICU patients: a longitudinal study
    Priyanka Mehta, Partha Chattopadhyay, Ramakant Mohite, Ranit D’Rozario, Purbita Bandopadhyay, Jafar Sarif, Yogiraj Ray, Dipyaman Ganguly, Rajesh Pandey · 2023 · Life Science Alliance
  81. Recent cannabis use affects the association between baseline immune markers and long-term outcomes in psychosis
    Isabel Kreis, Kristin Fjelnseth Wold, Gina Åsbø, Martha Werner, Magnus Johan Engen, Nils Eiel Steen, Ingrid S. Melle, Mashhood Ahmed Sheikh, Maren Caroline Frogner Werner, Eivind Bakken et al. · 2024 · Neuroscience Applied
  82. A Serum Analysis before and after Antidepressant Treatment in Major Depression: A Pilot Study
    Murielle F. Girard, Karine Vuillier-Devillers, Émilie Pinault, Barbara Bessette, Brigitte Plansont, D. Malauzat · 2015 · Clinical Medicine Insights Psychiatry
  83. Treatment of Childhood Trauma: Pharmacological Approach
    Isabella Panaccione, Gianluigi Di Cesare, Gabriele Sani, Giuseppe Ducci · 2020 · Springer eBooks
  84. A Matched Case-Control Study of the Serum Level and Gene Expression of IL-6 and IL-12 in Patients with Schizophrenia Spectrum Disorder: An Azeri Acute Phase/Recent-Onset Psychosis Survey (ARAS) Study
    Ali Reza Shafiee‐Kandjani, Morteza Asadi, Sara Farhang, Dariush Shanebandi, Milad Asadi, Arash Mohagheghi, Richard Bruggeman · 2024 · Archives of Neuroscience
  85. Schizophrenia - Recent Advances and Patient-Centered Treatment Perspectives
    Jane Yip · 2022 · IntechOpen eBooks
  86. Decreased serum cortisol levels in women with major depressive disorder and suicidal ideation in the antenatal period
    Giulia Lombardo, Kristi Priestley, Katie M. Hazelgrove, Rebecca H. Bind, Alessandra Biaggi, Susan Conroy, Andrea Du Preez, Naghmeh Nikkheslat, Sarah Osborne, Susan J. Pawlby et al. · 2026 · Brain Behavior and Immunity
  87. Remission and Immunological Profile of Patients in the Initial Stages of Schizophrenia
    Н. Н. Петрова, St Petersburg, Russian Federation, Valeria S. Serazetdinova, V.V. Dorofeуkov · 2024 · Doctor Ru
  88. THE ROLE OF CYTOKINES IN SCHIZOPHRENIA
    Iva Binić, Jovana Petrović, Jovana Antonijević, Dimitrije Pančić, Maša Golubović, Filip Petrović, Jelena Branković, Olivera Žikić · 2023 · Acta Medica Medianae
  89. Project 1: investigating the polyclonal nature of Glioblastoma through the development of a 3-dimensional spheroid model And Project 2: Investigating TNF-α in first episode psychosis medication naïve schizophrenia patients to demographically controlled individuals and pharmacological manipulation of TNF-α release
    Katherine L. Eales · 2014 · University of Birmingham Institutional Research Archive (University of Birmingham)
  90. The Modeling and Advanced Controller Design of Wind, PV and Battery Inverters
    Junbiao Han · 2014
  91. The psychoneuroimmunology of music: modulation of psychological state, stress levels and immune response through participatory interventions
    Daisy E. Fancourt · 2016 · UCL Discovery (University College London)
  92. Traumatic life experiences and major depression: an overview
    Luisa De Risio, Claudia Battaglia, Giovanni Camardese, Bruna Mattioli, Marco Di Nicola, Federica Vellante, Vittoria Ardino, Luigi Janiri · 2016 · INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY TRAUMA STUDIES
  93. Central and peripheral molecular profiling of sex differences in schizophrenia, major depressive disorder, and controls
    Jordan M. Ramsey · 2015 · Apollo (University of Cambridge)
  94. Assessment the Serum Level of IL6, IL10 versus Neuregulin 1 among Schizophrenic Patients in Iraq
    Manal Mohammed Khadhim · 2017 · Journal of Medical Science And clinical Research
  95. Distinct Plasma Cytokine Levels during Early Abstinence in Amphetamine-Dependent Women with and Without Psychosis
    Shin-Chang Kuo, Yi‐Wei Yeh, Chun Yen Chen, Chang Chih Huang, Mei-Chen Shih, Che-Hung Yen, Pei Shen Ho, Chih‐Sung Liang, Chang‐Chih Tsou, Bao Zhu Yang et al. · 2018 · Neuropsychiatry
  96. Exploring the application of psychiatric genetic counselling within the UK.
    Spencer-Tansley, Rosa Elise · 2016 · Bournemouth University Research Online (Bournemouth University)
  97. Early-life stress and inflammatory cytokines in psychoses: from bench to community-based research
    Fabiana Maria das Graças Corsi Zuelli · 2020 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  98. Pronounced immunological abnormalities in unmedicated first episode as compared to chronic schizophrenia patients
    Berko Milleit, Jana Hesse, Kerstin Langbein, Kristin Rödiger, Christine Milleit, Ute‐Christiane Meier, Peter Ulrich Elsner, Uta‐Christina Hipler, Stefan Smesny · 2019 · Neurology Psychiatry and Brain Research
  99. Interaction between the immune and metabolic systems in different stages of schizophrenia spectrum disorders
    Roman Balõtšev · 2020 · DSpace repository (University of Tartu)
  100. Cardiovascular Manifestations in Schizophrenia
    Federica Calorio, Cristina Grazia Catania, Matteo Rocchetti · 2020 · Springer eBooks